Vir Biotechnology EVP, General Counsel and Corp Sec Vanina de Verneuil reports sale of $41,939.262 in common shares

• Vir Biotechnology EVP, general counsel, corporate secretary Vanina de Verneuil sold 1,343 shares of common stock at $11.334 on Nov. 2, 2026.
• She sold another 2,407 shares of common stock at $11.1 on Nov. 3, 2026.
• Her direct beneficial ownership stood at 110,193 shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vir Biotechnology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-070025), on November 04, 2026, and is solely responsible for the information contained therein.